Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1374)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2746)
  2. Department of Medicine (2703)
  3. Solid Tumor Oncology Division (2002)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (206)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2819)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mechanisms governing endogenous thymic regeneration
    Meeting Abstract

    Wertheimer, T.; Velardi, E.; Tsai, J.; Cooper, K.; Ottmüller, K. J.; Mokthari, Z.; Butler, J. M.; Rafii, S.; van den Brink, M. R. M.; Dudakov, J. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacological inhibition of luteinizing hormone signaling promotes HSC quiescence and hematopoietic regeneration
    Meeting Abstract

    Velardi, E.; Tsai, J.; Radtke, S.; Cooper, K.; Argyropoulos, K.; Jae-Hung, S.; Shono, Y.; Jenq, R. R.; Hanash, A. M.; Moore, M. A. S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Nrf2 is a critical mediator of CD4 T cell-induced acute graft-versus-host disease
    Meeting Abstract

    Tsai, J.; Velardi, E.; Shono, Y.; Argyropoulos, K.; Smith, O. M.; Lazrak, A.; Liu, C.; Murphy, G. F.; Fu, Y. Y.; Hanash, A. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • SETBP1 and NRAS mutations are frequent events in post-myeloproliferative neoplasm acute myeloid leukemia (post-MPN AML) lacking JAK-STAT activating mutations
    Meeting Abstract

    Menghrajani, K.; Rapaport, F.; McNamara, C. J.; Devlin, S. M.; Famulare, C.; Patel, M.; Medina, J.; Sandy, L.; Kosiorek, H.; Singer Weinberg, R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival survival: On behalf of the ALWP of the EBMT and the MSKCC
    Meeting Abstract

    Malard, F.; Labopin, M.; Cho, C.; Blaise, D.; Papadopoulos, E. B.; Passweg, J. R.; O'Reilly, R.; Milpied, N.; Maloy, M.; Volin, L.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genetically-defined AML subgroups represent diverse epigenetic heterogeneity landscape
    Meeting Abstract

    Li, S.; Chen, X.; Wang, J.; Meydan, C.; Glass, J. L.; Shih, A. H.; Valk, P. J. M.; Delwel, R.; Levine, R. L.; Mason, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Characteristics and outcome of patients with acute myeloid leukemia and t(6;9)(p22;q34)
    Meeting Abstract

    Kayser, S.; Hills, R. K.; Luskin, M. R.; Brunner, A. M.; Shaw, C.; Westermann, J.; Menghrajani, K.; Baer, M. R.; Elliott, M. A.; Perl, A. E.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save